OBI — Ondine Biomedical Share News
0.000.00%
- £77.17m
- £71.78m
- CA$2.65m
Ondine Biomedical - Update on US Phase 3 Pivotal Study
RCS - Ondine Biomedical - Keynote Address at 8th Annual Photodynamic Day
Brief: Ondine Lantern Phase 3 Database Lock Expected Within A Week; Top-Line Results In 1-2 Weeks
Ondine Biomedical - Leeds Drops SSIs by 78.5% in Complex Brain Surgery
Brief: Ondine Biomedical Expects 2026 To Be A Defining Year For Company
Ondine Biomedical - Notice of AGM
Ondine Biomedical - 2025 Full Year Results and Annual Report
Ondine Biomedical - Notice of Results and Investor Presentation
RCS - Ondine Biomedical - Steriwave ICU Study Outcomes Presented at CSRT2026
Ondine Biomedical - Notification of major holdings - hInsight-NX, LLC
Ondine Biomedical - Notification of major holdings - Carolyn Cross
Ondine Biomedical - Notification of major holdings - Pentwater
RCS - Ondine Biomedical - Ondine Presented Steriwave Data at IPC 2026
Brief: Ondine Biomedical Raises £5 Million
Brief: Ondine Biomedical Announces Proposed Fundraising Of £5 Mln
Ondine Biomedical - Proposed c.£5 million (C$9.23 million) Fundraise
RCS - Ondine Biomedical - ICU Study to be Presented at 2026 CACCN Conference
RCS - Ondine Biomedical - Two Abstracts Accepted at World Congress
Ondine Biomedical - Business Update